Commonwealth Financial Services »

Vertex Pharmaceuticals Incorporated shares owned by Commonwealth Financial Services

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Commonwealth Financial Services from 13F filings

Historical chart of Commonwealth Financial Services investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Commonwealth Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Commonwealth Financial Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $220k 485 453.66
2025-06-30 $206k 462 445.52
2025-03-31 $226k 465 485.16
2024-09-30 $205k 437 470.11

More positions owned by Commonwealth Financial Services

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchng Traded Fd Vi Ft Vest Us Equit (UXOC)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Ea Series Trust Us Quan Momentum (QMOM)
First Tr Exchng Traded Fd Vi Smith Unconstrai (UCON)
Ea Series Trust Freedom 100 Em (FRDM)
Fidelity Comwlth Tr Nasdaq Compsit (ONEQ)
NVIDIA Corporation (NVDA)
Ishares Tr Ibonds 27 Etf (IBDS)
Ishares Tr Ibds Dec28 Etf (IBDT)
Ishares Tr Ibonds Dec 29 (IBDU)
Pacer Fds Tr Developed Mrkt (ICOW)

View all positions for Commonwealth Financial Services

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Victory Capital Management
FMR
Jennison Associates
Norges Bank Investment Management

View all funds holding Vertex Pharmaceuticals Incorporated